分子的新型作用:眼科疾病的终结?
Si-Yu Li1, Rong-Yue Xue1, Hao Wu1
1Henan Eye Institute, Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Pharmaceuticals (Basel, Switzerland)
|November 25, 2023
概括
分子 (H2) 通过减少氧化损伤和炎症,提供对眼睛疾病的保护作用. 需要进一步的研究来优化其在眼科的治疗用途.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学科学 生物医学科学
- 医疗气体治疗 医疗气体治疗
背景情况:
- 分子 (H2) 是一种具有抗氧化和抗炎性能的无毒气体.
- H2可以通过气体,富水 (HRW) 或富盐水 (HRS) 给药.
- 新出现的证据表明,H2在各种眼科疾病中具有治疗潜力.
研究的目的:
- 审查分子 (H2) 的特性.
- 总结H2在眼科疾病中的治疗作用.
- 突出最近在H2管理和潜在机制方面的进展.
主要方法:
- 对眼科中分子的研究进行文献综述.
- 对H2的特性,施用方法和治疗机制的分析.
- 专注于临床应用和未来研究方向.
主要成果:
- 2通过减轻氧化应激和炎症,对细胞产生保护和修复作用.
- 在治疗干眼病和角膜内皮损伤等疾病方面,H2已经显示出有前途.
- 临床试验表明H2作为治疗失明相关疾病的治疗剂的潜力.
结论:
- 分子 (H2) 对眼科疾病具有显著的治疗潜力.
- 目前的证据支持H2在控制氧化应激和眼睛炎症方面的作用.
- 需要进行更大规模的临床研究,以确定眼科治疗的最佳H2剂量和管理.
相关概念视频
Hydrogen Bonds
8.5K
A hydrogen bond is formed when a weakly positive hydrogen atom already bonded to one electronegative atom (for example, the oxygen in the water molecule) is attracted to another electronegative atom from another polar molecule, such as water (H2O), hydrogen fluoride (HF), or ammonia (NH3). The huge electronegativity difference between the H atom (2.1) and the atom to which it is bonded (4.0 for an F atom, 3.5 for an O atom, or 3.0 for an N atom), combined with the very small size of an H atom...
8.5K
Open Angle Glaucoma: Treatment
456
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
456
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.3K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.3K
Reduction of Alkenes: Catalytic Hydrogenation
12.1K
Alkenes undergo reduction by the addition of molecular hydrogen to give alkanes. Because the process generally occurs in the presence of a transition-metal catalyst, the reaction is called catalytic hydrogenation.
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
12.1K
Peroxisomes
13.1K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
13.1K
Molecular Orbital Theory II
19.2K
Molecular Orbital Energy Diagrams
19.2K


